title: Did U.S. Orthopaedic Partners’ Medtech Deal Just Shift Johnson & Johnson’s (JNJ) Investment Narrative?
source: Yahoo
date: 2025-10-06
url: https://finnhub.io/api/news?id=2112ee75f7868432b35c219074b9c66f990594e98c6e49b2a261d631c3e5ff5a
In the past week, U.S. Orthopaedic Partners announced a collaboration with Johnson & Johnson, selecting the medtech company as its official vendor for total joint products across its clinical platform after a surgeon-led evaluation of product performance and durability. This agreement not only grants USOP access to advanced solutions such as the VELYS Robotic-Assisted Solution but also highlights a growing industry trend where physician-led management organizations collaborate closely with...
